The Development and Impact of Tuberculosis Vaccines.
From: Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom. d.young@imperial.ac.uk
Cell
- Publish Date: Feb 2006
- ISSN: 0092-8674
- Volume: 124
- Issue: 4
- Pages: 683-7
- Medium: Print
- Language: English
- Citation (JAMA): Young Douglas, Dye Christopher, et al. The Development and Impact of Tuberculosis Vaccines.. Cell Feb 2006;124:683-7
Abstract
Vaccination is expected to make a major contribution to the goal of eliminating tuberculosis worldwide by 2050. But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control.
Mesh Headings (Keywords): Animals, BCG Vaccine, Clinical Trials as Topic, Humans, Immunization Programs, Incidence, Technology, Pharmaceutical, Tuberculosis, Tuberculosis Vaccines, Tuberculosis, Pulmonary, Vaccines, Combined, World Health
Check for Full Text / PubMed Unique Identifier (PMID): 16497578
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.